NCT05465954 2026-01-12
Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
Mayo Clinic
Phase 2 Recruiting
Mayo Clinic
University of Florida
Mayo Clinic
Maastricht Radiation Oncology
Jonsson Comprehensive Cancer Center
Northwestern University